NERLYNX neratinib (as maleate) 40 mg

Availability: Reduction in supply until supply is exhausted Deletion from market: 30 Jul 2025

SUPREMINE ER phentermine (as hydrochloride) 15 mg

Availability: Reduction in supply until supply is exhausted Deletion from market: 31 Dec 2025

SUPREMINE ER phentermine (as hydrochloride) 30 mg

Availability: Reduction in supply until supply is exhausted Deletion from market: 31 Dec 2025

SUPREMINE ER phentermine (as hydrochloride) 40 mg

Availability: Reduction in supply until supply is exhausted Deletion from market: 31 Dec 2025

NEORECORMON epoetin beta (rch) 2000 IU/0.3 mL

Availability: Reduction in supply until supply is exhausted Deletion from market: 24 Nov 2025

NEORECORMON epoetin beta (rch) 3000 IU/0.3 mL

Availability: Reduction in supply until supply is exhausted Deletion from market: 06 Oct 2025

NEORECORMON epoetin beta (rch) 4000 IU/0.3 mL

Availability: Reduction in supply until supply is exhausted Deletion from market: 27 Oct 2025

NEORECORMON epoetin beta (rch) 5000 IU/0.3 mL

Availability: Reduction in supply until supply is exhausted Deletion from market: 29 Sep 2025

NEORECORMON epoetin beta (rch) 6000 IU/0.3 mL

Availability: Reduction in supply until supply is exhausted Deletion from market: 12 Sep 2025

NEORECORMON epoetin beta (rch) 10 000 IU/0.6 mL

Availability: Reduction in supply until supply is exhausted Deletion from market: 05 Jan 2026

INDERAL propranolol hydrochloride 10mg

Availability: Reduction in supply until supply is exhausted Deletion from market: 01 Dec 2025

INDERAL propranolol hydrochloride 40mg

Availability: Reduction in supply until supply is exhausted Deletion from market: 01 Dec 2025